Importantly, patients with low METTL6 levels in HCC exhibit increased survival rates, aligning with previous findings in human breast cancer cells (118), indicating a context-dependent role for METTL6 in cell growth across various cell types (119). The gene discussed is METTL6; the disease is breast carcinoma.